Annual ROE
28.35%
+24.50%+636.36%
December 31, 2022
Summary
- As of February 10, 2025, EUCR annual return on equity is 28.35%, with the most recent change of +24.50% (+636.36%) on December 31, 2022.
Performance
EUCR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
3.10%
+0.59%+23.51%
December 31, 2022
Summary
- As of February 10, 2025, EUCR quarterly return on equity is 3.10%, with the most recent change of +0.59% (+23.51%) on December 31, 2022.
- Over the past year, EUCR quarterly ROE has dropped by -0.78% (-20.10%).
Performance
EUCR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EUCR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +636.4% | -20.1% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
EUCR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -86.4% | -20.1% | -19.0% |
| 5 y | 5-year | at high | -86.4% | -49.4% | -19.0% |
| alltime | all time | at high | -86.4% | -49.4% | -19.0% |
Eucrates Biomedical Acquisition ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 28.35%(+636.4%) | 3.10%(+23.5%) |
| Sep 2022 | - | 2.51%(-15.2%) |
| Jun 2022 | - | 2.96%(-6.9%) |
| Mar 2022 | - | 3.18%(-18.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | 3.85% | 3.88%(+6.6%) |
| Sep 2021 | - | 3.64%(-32.2%) |
| Jun 2021 | - | 5.37%(-12.4%) |
| Mar 2021 | - | 6.13% |
FAQ
- What is Eucrates Biomedical Acquisition annual return on equity?
- What is the all time high annual ROE for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition annual ROE year-on-year change?
- What is Eucrates Biomedical Acquisition quarterly return on equity?
- What is the all time high quarterly ROE for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition quarterly ROE year-on-year change?
What is Eucrates Biomedical Acquisition annual return on equity?
The current annual ROE of EUCR is 28.35%
What is the all time high annual ROE for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high annual return on equity is 28.35%
What is Eucrates Biomedical Acquisition annual ROE year-on-year change?
Over the past year, EUCR annual return on equity has changed by +24.50% (+636.36%)
What is Eucrates Biomedical Acquisition quarterly return on equity?
The current quarterly ROE of EUCR is 3.10%
What is the all time high quarterly ROE for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high quarterly return on equity is 6.13%
What is Eucrates Biomedical Acquisition quarterly ROE year-on-year change?
Over the past year, EUCR quarterly return on equity has changed by -0.78% (-20.10%)